Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Gastroenterology Disposables Market size is poised to grow at over 14.2% CAGR during the forecast period i.e., between 2025-2037.
The growth of the market can be attributed to the increasing number of cases of infectious diseases across the globe, coupled with the growing prevalence of diseases associated with the digestive system. In 2019, more than 20% of the adult population in the United States was diagnosed with gastrointestinal conditions, whereas, about 19% adults were diagnosed with gastrointestinal disorders in EU-5 in the same year. Along with these, high risk of hospital acquired infections (HAIs), especially in developing nations, and rising technological advancements to develop sophisticated gastroenterology equipment are also expected to drive market growth in the upcoming years. Furthermore, upsurge in the number of regulatory approvals for disposable/single use medical devices is projected to offer ample growth opportunities to the market in the near future.
Gastroenterology Disposables Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Cases of Infectious Diseases Across the Globe
- Growing Prevalence of Diseases Associated with the Digestive System
Challenges
- High Cost of Gastroenterology Disposables
Gastroenterology Disposables Market: Key Insights
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
14.2% |
|
Regional Scope |
|
Gastroenterology Disposables Segmentation
The market is segmented by affected organ into stomach, esophagus, small intestine, pancreas, gallbladder, liver, colon, and bile ducts, out of which, the colon segment is anticipated to witness significant growth in the global gastroenterology disposables market over. This can be accounted to the growing occurrence of rectal and colon cancer around the world, particularly among the elderly people. Apart from this, government initiatives to spread awareness about cancer, and the necessity of screening the condition is also predicted to boost the growth of the market segment in the future. Additionally, on the basis of end user, the hospitals segment is assessed to acquire the largest share over the forecast period owing to the large number of patient admission, and high preference of patients to get treated by trained professionals in a hospital facility.
Our in-depth analysis of the global gastroenterology disposables market includes the following segments:
|
By Affected Organ |
|
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportGastroenterology Disposables Industry - Regional Synopsis
On the basis of geographical analysis, the global gastroenterology disposables market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region.Asia Pacific industry is estimated to dominate majority revenue share by 2037, backed by growing technological advancements in the healthcare sector, and large patient pool in the region. Moreover, the market in the North America region is anticipated to gain the largest market share throughout the forecast period ascribing to the high healthcare expenditure, and well-established medical infrastructure in the region. According to the Centers for Medicare & Medicaid Services (CMS), the health spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion, or USD 12,530 per person. In addition, strong presence of prominent market players is also projected to boost the market growth in the region in the coming years.
Companies Dominating the Gastroenterology Disposables Landscape
- Corinth MedTech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boston Scientific Corporation
- Hill-Rom Holdings, Inc.
- HOYA Corporation
- KARL STORZ SE & Co. KG
- OBP Medical Corporation
- Coloplast A/S
- 3NT Medical Ltd.
- OTU Medical Inc.
- Prosurg Inc.
In the News
-
August 2021- The U.S. Food and Drug Administration (FDA) gave clearance to 3NT’s specialized Peregrine endoscope, which is designed to help diagnose and treat disorders, including polyps and cancers.
Author Credits: Radhika Pawar
- Report ID: 3998
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
